Lonikan
Synthetic adrenocorticosteroid with prevailing mineralocorticoid action. Indicated for the treatment of the salt-losing adrenogenital syndrome, primary or secondary adrenocortical insufficiency in Addison disease.
Therapeutic Area
Synthetic Adrenocorticoid
Active Ingredient
Fludrocortisone
Line
Cardiometabolism
Pharmaceutical Form
0.1 mg tablets x 50
